Don Robbins, President and CEO of CSMG Technologies, said, “We are continuing to attract what we believe to be a top LTC management team that is working in coordination with our quality elecrtrosurgery generator and hand instrument designers and manufacturers, as we begin to implement worldwide technology commercialization and sales.”

Frank D’Amelio, President of Live Tissue Connect, Inc. said, “We are very pleased that David is joining LTC as its Sales and Marketing Director, and will also be heading up our GSM Medical Division. David has had a successful career in sales and marketing of medical devices with four other advanced technology companies. Attracting a leader with this level of experience, and a wide skill set, will be instrumental to our success. Since 2007, David has made significant contributions toward our FDA clearance efforts, gaining our CE Mark, developing our business strategy, clinical testing, and is presently setting up a worldwide distribution network.”

In addition to his position as LTC’s Director of Worldwide Sales and Marketing, Mr. Colvin has been appointed General Manager of Live Tissue Connect’s GSM Medical Division. This division is focused on marketing LTC’s innovative sealing and cutting technology into the General Surgery and Gynecology arenas.

Mr. Colvin added, “I am pleased to accept this position to commercialize a revolutionary medical technology and work with a group of medical device veterans that have the experience, skills and contacts to what I believe adds to the success of LTC. The efficacy demonstrated in clinical applications where our tissue welding technology has been utilized is impressive, and the number and variety of potential human applications is staggering. The opportunity to bring to market an entire family of bipolar RF sealer, cutters and staple-less staplers, that have been in clinical use in Eastern Europe is quite unique.”

Mr. Colvin has extensive sales and marketing experience in the medical device industry. He has earned numerous sales awards selling devices to the Orthopaedic, Gynecology, General Surgery, and Urology markets and has held senior marketing and sales management positions with Bristol-Myers Squibb, W.L. Gore & Associates, Circon Corporation and Urologix.

About Live Tissue Connect

LTC's surgical tissue bonding / welding device is a patented platform technology that bonds and reconnects human soft tissue through fusion, in contrast with conventional wound closing devices such as sutures, staples, sealant, or glues. LTC currently holds a total of approximately 44 patents and patent applications in the U.S., Australia, Canada, European Union, Ukraine and other countries.

For further information on CSMG Technologies and its various subsidiaries, please visit our website at www.csmgtechinternational.com.